Neurointerventional Device MarketThe global neurointerventional device market, valued at USD 2.6 billion in 2023, is ...

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of ...

The safety and effectiveness of the Neuroguard IEP (Contego Medical)—a three-in-one carotid stent system with integrated ...

A 43-year-old man who developed numbness and impaired fine motor skills in his left arm lasting approximately 10 min while chanting during a football match, attended our emergency room. The patient, ...

The analysis wasn’t prespecified, and with no clear explanation, the field awaits insights from the larger BHF PROTECT-TAVI ...

Stroke is one of the leading causes of death and disability in India. The estimated prevalence of stroke ranges from 84 to ...

The PROTECTED transcatheter aortic valve replacement (TAVR) trial could not show that the use of cerebral embolic protection (CEP ...

The lawsuit is linked to Emboline’s embolic medical device, which is intended to offer protection from ischemic events.

The following is a summary of “Risk of thromboembolic events in patients with nephrotic syndrome and relatively high albumin levels: a study over 10 years,” published in the September 2024 issue of ...

Extending the simple CT scan administered to all acute stroke patients to include the upper part of the heart increased ...